Back to top

This division initiates research and development in order to generate the required clinical proof of concept data for its chosen reformulations. The N4 Pharma Directors believe that this will lead to licensing deals being entered into with pharmaceutical companies. Such deals would typically involve upfront milestone payments and royalty payments to follow in later years and beyond. N4 Pharma outsources its research and development, thereby reducing its overheads.

Generics in the pipeline

Sildenafil

Erectile Dysfunction
Laboratory

Sartans

Anti-hypertensive

Aprepitant

Oncology and pain relief

Duoloxetine

Premature ejaculation